These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 29414320

  • 1. Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors of complete remission in primary glomerulonephritis.
    Chanrat E, Worawichawong S, Radinahamed P, Sathirapongsasuti N, Nongnuch A, Assanatham M, Udomsubpayakul U, Kitiyakara C.
    Cytokine; 2018 Apr; 104():1-7. PubMed ID: 29414320
    [Abstract] [Full Text] [Related]

  • 2. Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis.
    Worawichawong S, Worawichawong S, Radinahamed P, Muntham D, Sathirapongsasuti N, Nongnuch A, Assanatham M, Kitiyakara C.
    Kidney Blood Press Res; 2016 Apr; 41(6):997-1007. PubMed ID: 27988512
    [Abstract] [Full Text] [Related]

  • 3. Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    Ngamjanyaporn P, Worawichawong S, Pisitkun P, Khiewngam K, Kantachuvesiri S, Nongnuch A, Assanatham M, Sathirapongsasuti N, Kitiyakara C.
    PLoS One; 2022 Apr; 17(3):e0263778. PubMed ID: 35271583
    [Abstract] [Full Text] [Related]

  • 4. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B, Dispan R, Radinahamed P, Kitiyakara C.
    BMC Nephrol; 2018 Sep 21; 19(1):246. PubMed ID: 30241508
    [Abstract] [Full Text] [Related]

  • 5. [Changes of urinary monocyte chemotactic protein 1 and epidermal growth factor and their correlations with clinicopathology in idiopathic membranous nephropathy patients].
    Zheng S, Zhao ZH, Liu ZJ, Wang DH, Liu DW, Liu ZS.
    Zhonghua Yi Xue Za Zhi; 2020 Apr 28; 100(16):1230-1234. PubMed ID: 32344494
    [Abstract] [Full Text] [Related]

  • 6. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Apr 28; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 7. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L, Li XQ, Chang DY, Zhang H, Li JJ, Wu SL, Zhang LX, Chen M, Zhao MH.
    Nephrol Dial Transplant; 2020 Feb 01; 35(2):291-297. PubMed ID: 30357416
    [Abstract] [Full Text] [Related]

  • 8. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy.
    Torres DD, Rossini M, Manno C, Mattace-Raso F, D'Altri C, Ranieri E, Pontrelli P, Grandaliano G, Gesualdo L, Schena FP.
    Kidney Int; 2008 Feb 01; 73(3):327-33. PubMed ID: 17943082
    [Abstract] [Full Text] [Related]

  • 9. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases.
    Chen YM, Lin SL, Chiang WC, Wu KD, Tsai TJ.
    Kidney Int; 2006 Apr 01; 69(8):1410-5. PubMed ID: 16541021
    [Abstract] [Full Text] [Related]

  • 10. Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study.
    Tofik R, Ohlsson S, Bakoush O.
    PLoS One; 2014 Apr 01; 9(1):e87857. PubMed ID: 24489972
    [Abstract] [Full Text] [Related]

  • 11. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy.
    Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, Paradies G, Caldarulo E, Infante B, Schena FP.
    Kidney Int; 2000 Jul 01; 58(1):182-92. PubMed ID: 10886563
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis.
    Idasiak-Piechocka I, Miedziaszczyk M, Woźniak A, Pawliczak E, Kaczmarek E, Oko A.
    Am J Physiol Cell Physiol; 2023 Nov 01; 325(5):C1267-C1275. PubMed ID: 37721004
    [Abstract] [Full Text] [Related]

  • 13. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M, Alexopoulos E, Papagianni A, Pantzaki A, Bantis C, Dovas S, Economidou D, Leontsini M, Memmos D.
    Nephrology (Carlton); 2009 Sep 01; 14(6):613-20. PubMed ID: 19143943
    [Abstract] [Full Text] [Related]

  • 14. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH, Abraham AG, Xu Y, Schelling JR, Feldman HI, Sabbisetti VS, Ix JH, Jogalekar MP, Coca S, Waikar SS, Shlipak MG, Warady BA, Vasan RS, Kimmel PL, Bonventre JV, Denburg M, Parikh CR, Furth S, CKD Biomarkers Consortium, CKD Biomarker consortium.
    J Am Soc Nephrol; 2021 Oct 01; 32(10):2664-2677. PubMed ID: 34544821
    [Abstract] [Full Text] [Related]

  • 15. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
    Kalavrizioti D, Gerolymos M, Rodi M, Kalliakmani P, Provatopoulou S, Eleftheriadis T, Mouzaki A, Goumenos DS.
    Cytokine; 2015 Dec 01; 76(2):260-269. PubMed ID: 26307557
    [Abstract] [Full Text] [Related]

  • 16. Urinary fractalkine and monocyte chemoattractant protein-1 as possible predictors of disease activity of childhood glomerulonephritis.
    Aizawa T, Imaizumi T, Tsuruga K, Watanabe S, Yoshida H, Kumagai N, Ito E, Tanaka H.
    Tohoku J Exp Med; 2013 Dec 01; 231(4):265-70. PubMed ID: 24284376
    [Abstract] [Full Text] [Related]

  • 17. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM, Serova AG, Kuznetsova EI, Bulanova ML, Novikov PI, Kozlovskaya LV, Moiseev SV.
    Ter Arkh; 2017 Dec 01; 89(6):48-55. PubMed ID: 28745689
    [Abstract] [Full Text] [Related]

  • 18. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN, Chebotareva NV, Kozlovskaia LV, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2006 Dec 01; 78(5):9-14. PubMed ID: 16889042
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.
    Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM.
    J Pediatr Urol; 2013 Dec 01; 9(6 Pt A):838-45. PubMed ID: 23228281
    [Abstract] [Full Text] [Related]

  • 20. Monocyte chemoattractant protein-1 levels in patients with glomerular disease.
    Rovin BH, Doe N, Tan LC.
    Am J Kidney Dis; 1996 May 01; 27(5):640-6. PubMed ID: 8629622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.